Case number: 1:19-bk-12749 - Cempra Pharmaceuticals, Inc. - Delaware Bankruptcy Court

Case Information
  • Case title

    Cempra Pharmaceuticals, Inc.

  • Court

    Delaware (debke)

  • Chapter

    11

  • Judge

    Laurie Selber Silverstein

  • Filed

    12/27/2019

  • Last Filing

    07/13/2021

  • Asset

    Yes

  • Vol

    v

Docket Header
CLOSED, JNTADMN, CLMSAGNT



U.S. Bankruptcy Court
District of Delaware (Delaware)
Bankruptcy Petition #: 19-12749-LSS

Assigned to: Bankruptcy Judge Laurie Selber Silverstein
Chapter 11
Voluntary
Asset



Debtor disposition:  Discharge Not Applicable
Date filed:  12/27/2019
Date terminated:  07/13/2021

Debtor

Cempra Pharmaceuticals, Inc.

44 Whippany Road
Suite 280
Morristown, NJ 07960
MORRIS-NJ
Tax ID / EIN: 20-3905814

represented by
David R. Hurst

McDermott Will & Emery LLP
The Nemours Building
1007 North Orange Street
4th Floor
Wilmington, DE 19801
usa
302-485-3930
Fax : 302-351-8711
Email: dhurst@mwe.com

U.S. Trustee

U.S. Trustee

Office of the United States Trustee
J. Caleb Boggs Federal Building
844 King Street, Suite 2207
Lockbox 35
Wilmington, DE 19801
(302)-573-6491

 
 
Claims Agent

Kurtzman Carson Consultants, LLC dba Verita Global

222 N. Pacific Coast Highway
Suite 300
El Segundo, CA 90245
 
 

Latest Dockets

Date Filed#Docket Text
07/13/2021Bankruptcy Case Closed (LB) (Entered: 07/13/2021)
07/13/20217Final Decree and Order Closing Chapter 11 Cases Signed on 6/30/2021 (LB) (Entered: 07/13/2021)
02/21/20206Amended Schedules/Statements - Jointly Administered Entity filed: Sch D, Sch E-F, , Decl Concerning Debtors Schs,. Filed by Cempra Pharmaceuticals, Inc.. (Hurst, David) (Entered: 02/21/2020)
02/04/20205Schedules/Statements filed: , Stmt of Financial Affairs,. Filed by Cempra Pharmaceuticals, Inc.. (Hurst, David) (Entered: 02/04/2020)
02/04/20204Schedules/Statements filed: Sch A-B, Sch D, Sch E-F, Sch G, Sch H, , Sum of Assets and Liabilities, Decl Concerning Debtors Schs,. Filed by Cempra Pharmaceuticals, Inc.. (Hurst, David) (Entered: 02/04/2020)
12/30/20193Order (I) Directing Joint Administration of Cases and (II) Waiving Certain Requirements of Bankruptcy Rule 2002(n) - An order has been entered in this case consolidating this case with the case of Melinta Therapeutics, Inc., Case No. 19-12748 (LSS), for procedural purposes only and providing for its joint administration in accordance with the terms thereof. The docket in Case No. 19-12748 (LSS) should be consulted for all matters affecting this case. Signed on 12/30/2019 (LJJ) (Entered: 12/30/2019)
12/27/2019Judge Laurie Selber Silverstein added to case (LB) (Entered: 12/27/2019)
12/27/20192Receipt of filing fee for Voluntary Petition (Chapter 11)(19-12749) [misc,volp11a] (1717.00). Receipt Number 9579297, amount $1717.00. (U.S. Treasury) (Entered: 12/27/2019)
12/27/20191Chapter 11 Voluntary Petition of Cempra Pharmaceuticals, Inc.. Fee Amount $1717. Filed by Cempra Pharmaceuticals, Inc.. (Hurst, David) (Entered: 12/27/2019)